Significant research news last week included Netherlands-based argenx, release of positive Phase III results for its myasthenia gravis (gMG) candidate Vyvgart, and Regeneron announcement of Phase III ...

The US Food and Drug Administration (FDA) on Friday approved a subcutaneous (SC) formulation of Biogen and Eisai’s Alzheimer’s disease treatment Leqembi (lecanemab), branded as Leqembi Iqlik, for ...

US pharma giant Merck & Co today announced results evaluating Verquvo (vericiguat) in adult patients with stable chronic ...

The Bachem team shares insights on the evolving relationship between pharma companies and contract development and manufacturing organizations (CDMOs). Headquartered in Switzerland Bachem specializes ...

ITF Therapeutics, the US affiliate of privately-held Italian firm Italfarmaco, has announced publication of positive long-term safety and efficacy data for Duvyzat (givinostat) in Duchenne muscular ...

Fosun Pharma has inked a deal with fellow China-based Accro Bioscience that grants it exclusive rights to develop, manufacture, and commercialize its independently developed, highly selective ...

Santhera Pharmaceuticals, a Swiss specialty pharma company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases, has signed a deal with India’s ...

US pharma major Eli Lilly has temporarily halted UK shipments of its weight-loss drug Mounjaro (tirzepatide), Reuters reports.

Shares in Outlook Therapeutics, a US biopharma focused on enhancing the standard of care for Avastin (bevacizumab) for the treatment of retina diseases, closed 49% lower Thursday after the company ...

Shares of Ireland-headquartered Prothena Corp dipped 2.5% to $8.36, after the company announced results from the Phase I ASCENT clinical program in participants with early symptomatic Alzheimer’s ...

The global nasal spray market is undergoing significant growth, projected to reach over $59.41 billion by 2032, according to a report from Malvern Panalytical.

Center for Drug Evaluation and Research (CDER), Office of New Drugs has accepted a Letter of Intent for the qualification of liver stiffness measurement by vibration-controlled transient elastography ...